Joel McComb is leaving his post as senior vice president and general manager of Illumina's Life Sciences business to become chief operating officer at Synthetic Genomics. McComb departed Illumina and took on the new position at SGI on March 1.
Before his time at Illumina, McComb was at General Electric, where he was president of Healthcare Life Sciences-Discovery Systems, and he served as president of GE Healthcare, Interventional Medicine. He also previously served as president and CEO of Innovadyne Technologies, a liquid-handling technology firm.
McComb's departure agreement from Illumina entitles him to a severance payment of nearly $260,000.
Ulf Jönsson has joined PharmaDiagnostics as non-executive director, the firm said this week.
Jönsson previously served as CEO of Cellectricon. He also was a co-founder and CEO of Biacore, now part of GE Healthcare.